May 9, 2022
A Japanese health ministry panel will discuss whether to recommend approval for a batch of medicines at its meeting on May 12 including Solasia Pharma’s peripheral T-cell lymphoma (PTCL) drug. If endorsed, they are expected to land approval as early...read more